Adverse outcomes in non-trial like patients on commercial HeartMate 3 LVAD support

Authors

Laura Coyle, Advocate Aurora HealthFollow
Colleen Gallagher, Advocate Aurora HealthFollow
Nicole Graney, Advocate Aurora HealthFollow
Lisa Kukla, Advocate Aurora HealthFollow
Robin Paliga, Advocate Aurora HealthFollow
Kylie Hughes, Advocate Aurora HealthFollow
Rachel Pedersen, Advocate Aurora HealthFollow
Kathleen Schultz, Advocate Aurora HealthFollow
Adam JT Schuldt, Advocate Aurora HealthFollow
Nasir Sulemanjee, Advocate Aurora HealthFollow
Gregory P. Macaluso, Advocate Aurora HealthFollow
Sunil Pauwaa, Advocate Aurora HealthFollow
James Monaco, Advocate Aurora HealthFollow
Mark Dela Cruz, Advocate Aurora HealthFollow
William G. Cotts, Advocate Aurora HealthFollow
Nikhil Narang, Advocate Aurora HealthFollow
Patroklos S. Pappas, Advocate Aurora Health
Antone J. Tatooles, Advocate Aurora HealthFollow
Vinh Q. Chau, Advocate Aurora HealthFollow

Recommended Citation

Coyle L, Gallagher C, Graney N, et al. Adverse Outcomes in Non-Trial like Patients on Commercial HeartMate 3 LVAD Support. JHLT Open. 2023:100008. doi:10.1016/j.jhlto.2023.100008

Affiliations

Advocate Christ Medical Center, Aurora St. Luke's Medical Center

Type

Article